Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference 2022-07-26 20:30
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan 2022-07-26 20:05
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17 2022-07-26 20:00
Henlius HANQUYOU Received TGA Approval in Australia 2022-07-26 18:03
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre 2022-07-26 17:04
Largest-Ever Industry Report Reveals Video Meetings 3x More Effective and Companies Using Them Most Gain Advantage 2022-07-26 09:17
Angel Yeast Partners with PhaBuilder to Open PHA Factory 2022-07-25 23:00
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program 2022-07-25 21:59
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform 2022-07-25 12:30
Biotech Company RemeGen Commemorates International Self-Care Day with Health Initiatives 2022-07-25 11:00
US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL 2022-07-25 07:09
Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report 2022-07-22 19:25
Merck Launches its Uptune Program in Asia for Collaborating with Startups 2022-07-22 15:09
Congratulations! Kexing Biopharm (688136.SH) was awarded by the" Annual Top 20 Chinese Biopharmaceutical Entreprises" 2022-07-21 22:32
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy 2022-07-21 21:25
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
Mentice publishes the company's interim report for the period April - June 2022 2022-07-21 14:49
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
First report from the world's most ambitious sequencing project 2022-07-20 23:00
1 164 165 166 167 168 453